Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Third Annual Fecal Occult Blood Testing in Community Health Clinics.

Arnold CL, Rademaker A, Wolf MS, Liu D, Hancock J, Davis TC.

Am J Health Behav. 2016 May;40(3):302-9. doi: 10.5993/AJHB.40.3.2.

2.

Methylation pattern of ALX4 gene promoter as a potential biomarker for blood-based early detection of colorectal cancer.

Salehi R, Atapour N, Vatandoust N, Farahani N, Ahangari F, Salehi AR.

Adv Biomed Res. 2015 Nov 30;4:252. doi: 10.4103/2277-9175.170677. eCollection 2015.

3.

Strategies to improve repeat fecal occult blood testing cancer screening.

Davis TC, Arnold CL, Bennett CL, Wolf MS, Reynolds C, Liu D, Rademaker A.

Cancer Epidemiol Biomarkers Prev. 2014 Jan;23(1):134-43. doi: 10.1158/1055-9965.EPI-13-0795. Epub 2013 Nov 5.

4.

Barriers to colorectal cancer screening among women in rural central Pennsylvania: primary care physicians' perspective.

Rosenwasser LA, McCall-Hosenfeld JS, Weisman CS, Hillemeier MM, Perry AN, Chuang CH.

Rural Remote Health. 2013 Oct-Dec;13(4):2504. Epub 2013 Oct 8.

5.

FOBT completion in FQHCs: impact of physician recommendation, FOBT information, or receipt of the FOBT kit.

Davis TC, Arnold CL, Rademaker AW, Platt DJ, Esparza J, Liu D, Wolf MS.

J Rural Health. 2012 Summer;28(3):306-11. doi: 10.1111/j.1748-0361.2011.00402.x. Epub 2012 Jan 24.

6.
7.

Bringing an organizational perspective to the optimal number of colorectal cancer screening options debate.

Partin MR, Powell AA, Burgess DJ, Wilt TJ.

J Gen Intern Med. 2012 Mar;27(3):376-80. doi: 10.1007/s11606-011-1870-y. Epub 2011 Sep 14. Review.

8.

The priority is screening, not colonoscopy.

Woolf SH, Jones RM, Rothemich SF, Krist A.

Am J Public Health. 2009 Dec;99(12):2117-8; author reply 2118. doi: 10.2105/AJPH.2009.177584. Epub 2009 Oct 15. No abstract available.

9.

Trends in colorectal cancer screening utilization among ethnic groups in California: are we closing the gap?

Maxwell AE, Crespi CM.

Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):752-9. doi: 10.1158/1055-9965.EPI-08-0608.

10.

Offering annual fecal occult blood tests at annual flu shot clinics increases colorectal cancer screening rates.

Potter MB, Phengrasamy L, Hudes ES, McPhee SJ, Walsh JM.

Ann Fam Med. 2009 Jan-Feb;7(1):17-23. doi: 10.1370/afm.934.

11.

Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay.

Gr├╝tzmann R, Molnar B, Pilarsky C, Habermann JK, Schlag PM, Saeger HD, Miehlke S, Stolz T, Model F, Roblick UJ, Bruch HP, Koch R, Liebenberg V, Devos T, Song X, Day RH, Sledziewski AZ, Lofton-Day C.

PLoS One. 2008;3(11):e3759. doi: 10.1371/journal.pone.0003759. Epub 2008 Nov 19.

12.

Disparities in the receipt of fecal occult blood test versus endoscopy among Filipino American immigrants.

Maxwell AE, Danao LL, Crespi CM, Antonio C, Garcia GM, Bastani R.

Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):1963-7. doi: 10.1158/1055-9965.EPI-07-2800.

Supplemental Content

Support Center